On August 14, 2025, Elite Pharmaceuticals Inc. reported its financial results for the quarter ended June 30, 2025, and announced a conference call for August 15, 2025, to discuss the details. The filing also provided insights into the company's operations and financial conditions for the fiscal year 2026.